Disposition of 88544 shares by Mark Hahn of Verona Pharma at 1.9313 subject to Rule 16b-3
VRNA Stock | USD 63.32 2.94 4.44% |
About 68% of Verona Pharma's investor base is looking to short. The analysis of overall sentiment of trading Verona Pharma PLC stock suggests that many investors are alarmed at this time. The current market sentiment, together with Verona Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Verona Pharma PLC stock news signals to limit their universe of possible portfolio assets.
Filed transaction by Verona Pharma PLC Officer Chief Financial Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Read at macroaxis.com
Cash Flow Correlation
Verona Pharma's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Verona Pharma's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Verona Pharma Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Verona Pharma can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Verona Pharma PLC Historical Investor Sentiment
Investor biases related to Verona Pharma's public news can be used to forecast risks associated with an investment in Verona. The trend in average sentiment can be used to explain how an investor holding Verona can time the market purely based on public headlines and social activities around Verona Pharma PLC. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Verona Pharma's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Verona Pharma and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Verona Pharma news discussions. The higher the estimate score, the more favorable the investor's outlook on Verona Pharma.
Verona Pharma Fundamental Analysis
We analyze Verona Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Verona Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Verona Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Per Share
Cash Per Share Comparative Analysis
Verona Pharma is currently under evaluation in cash per share category among its peers. Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Verona Pharma PLC Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Verona Pharma stock to make a market-neutral strategy. Peer analysis of Verona Pharma could also be used in its relative valuation, which is a method of valuing Verona Pharma by comparing valuation metrics with similar companies.
Peers
Verona Pharma Related Equities
VTYX | Ventyx Biosciences | 5.98 | ||||
XFOR | X4 Pharmaceuticals | 2.43 | ||||
TERN | Terns Pharmaceuticals | 1.33 | ||||
AMLX | Amylyx Pharmaceuticals | 0.66 | ||||
MREO | Mereo BioPharma | 0.41 | ||||
VKTX | Viking Therapeutics | 1.08 | ||||
MDGL | Madrigal Pharmaceuticals | 1.65 | ||||
ABOS | Acumen Pharmaceuticals | 2.00 | ||||
PTGX | Protagonist Therapeutics | 2.16 | ||||
SNDX | Syndax Pharmaceuticals | 2.82 | ||||
APLS | Apellis Pharmaceuticals | 2.86 | ||||
MLTX | MoonLake Immunotherapeuti | 3.20 | ||||
IDYA | Ideaya Biosciences | 4.18 | ||||
DAWN | Day One | 4.59 | ||||
AKRO | Akero Therapeutics | 5.99 | ||||
INZY | Inozyme Pharma | 7.26 |
Complementary Tools for Verona Stock analysis
When running Verona Pharma's price analysis, check to measure Verona Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verona Pharma is operating at the current time. Most of Verona Pharma's value examination focuses on studying past and present price action to predict the probability of Verona Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Verona Pharma's price. Additionally, you may evaluate how the addition of Verona Pharma to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |